New Galderma Research Reveals More Than Half of Women Mistake Menopause — Related Skin Changes for Signs of Ageing
For best results when printing this announcement, please click on link below: New Galderma Research Reveals More Than Half of Women Mistake Menopause-Related Skin Changes for Signs of Ageing New clinical data identify optimized injectable aesthetics treatment protocol for menopause-induced skin changes 56% of women have experienced ‘The Menopausal Skin Misread’, admitting they first put menopause-related skin changes down to ageing, while fewer than a third (29%) recognized menopause as the cause(1) A significant knowledge gap remains: one in two women are unaware that hormonal changes during perimenopause and menopause can affect the skin, and 82% agree that better understanding the difference between menopause-related skin changes and general ageing would help them feel more informed and in control of their skincare decisions(1) New data from an investigator-initiated trial (IIT) led by Dr. Andreas Nikolis and supported by Galderma, demonstrated that a sequenced treatment approach using Restylane Skinboosters followed by Sculptra delivered significant improvements in skin hydration and remodeling across the face and décolletage in menopausal women, highlighting the value of preco
For best results when printing this announcement, please click on link below: New Galderma Research Reveals More Than Half of Women Mistake Menopause-Related Skin Changes for Signs of Ageing New clinical data identify optimized injectable aesthetics treatment protocol for menopause-induced skin changes 56% of women have experienced ‘The Menopausal Skin Misread’, admitting they first put menopause-related skin changes down to ageing, while fewer than a third (29%) recognized menopause as the cause(1) A significant knowledge gap remains: one in two women are unaware that hormonal changes during perimenopause and menopause can affect the skin, and 82% agree that better understanding the difference between menopause-related skin changes and general ageing would help them feel more informed and in control of their skincare decisions(1) New data from an investigator-initiated trial (IIT) led by Dr.
(1) Ahead of World Menopause Day, Galderma is calling attention to the misunderstood impact of menopause on the skin, helping to close the knowledge gap and empower women with the understanding needed to recognize and navigate menopause-related skin and aesthetic changes. This press release features multimedia. View the full release here: “Too many women are navigating changes in their skin without recognizing that menopause may be playing a role. Our research shows the scale of this knowledge gap and the need to move beyond a one-size-fits-all ageing narrative.
(1) New clinical data identify optimized injectable aesthetics treatment protocol for menopause-induced skin changes New results from an eight-month investigator-initiated trial (IIT) supported by Galderma and conducted by Dr. (2) “This first-of-its-kind clinical study provides compelling evidence that sequencing treatments can deliver significantly greater benefits than either approach alone in menopausal skin.
By first using Restylane Skinboosters to rapidly improve hydration and optimize the skin microenvironment, followed by Sculptra to stimulate collagen production and progressive tissue remodeling, more favorably, we are now able to address both the immediate and longer-term biologic changes associated with menopause. The result is a strongly supported scientific treatment strategy that combines rapid improvement in hydration with sustained enhancement in skin quality and remodeling, while achieving high levels of patient satisfaction. ” Dr.
(2) As part of its commitment to support women during this transition, Galderma has announced the launch of a new ‘Rewriting the Future of Your Skin, Own your Menopause Story’ campaign, bringing together science and the real experiences of women to shine a light on menopausal skin and help close the knowledge gap revealed by the research.
More information here Ahead of World Menopause Day on 18 October, Galderma is calling for a new conversation around menopausal skin: one that recognizes the role hormonal changes can play, separates menopausal skin and aesthetic changes from generic ageing narratives and gives women clearer information to understand what is happening to their skin to make more informed choices about what it needs. Ends Notes to editors: The research was conducted by Perspectus Global among a sample of 5,090 women who have experienced or are experiencing perimenopause or menopause across the UK, US, Brazil and China. The data was collected between 25 August and 1 September 2026.
About Galderma Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ — the skin — meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals.
Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: References 1. Galderma. Data on file.
Menopause patient survey; Wave 2 research. September 2026. 2. Nikolis A.
Prospective evaluation of treatment sequencing in menopausal patients: The role of preconditioning. Data on file. September 2026 3. Restylane(® )Skinboosters Vital Lidocane™.
EU Instructions for Use. 4. Sculptra(®). EU Instructions for Use.
Sc. com) +41 21 642 76 43